Close Menu

NEW YORK (GenomeWeb) – Quidel announced after the close of market on Monday that it expects its fourth quarter revenues to be in the range of $132 million to $133 million, which would be up 15 to 16 percent from a year ago.

In Q4 2017, the San Diego-based maker of rapid diagnostic testing solutions and molecular diagnostic systems reported revenues of $114.9 million.

The preliminary results would be even with the consensus Wall Street estimate of $132.1 million.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.